Iterative approach for the development of a CNS-active oxime reactivator for nerve agent exposure

被引：0
|
作者：
Malfatti, Michael [1 ]
Bennion, Brian [1 ]
Enright, Heather [2 ]
Be, Nicholas [1 ]
Hok, Saphon [3 ,6 ]
Cadieux, C. [4 ]
Carpenter, Timothy [1 ]
Lao, Victoria [1 ]
Kuhn, Edward [1 ]
McNerney, Margaret [5 ]
Lightstone, Felice [1 ]
Tuan Nguyen
Valdez, Carlos [3 ,6 ]
机构：
[1] Lawrence Livermore Natl Lab, Biosci & Biotechnol, Livermore, CA 94550 USA
[2] Lawrence Livermore Natl Lab, Biosci & Biotechnol, Livermore, CA 94550 USA
[3] Lawrence Livermore Natl Lab, Nucl & Chem Sci, Livermore, CA 94550 USA
[4] US Army, Med Res Inst Chem Def, Aberdeen, MD USA
[5] War Related Illness & Injury Study Ctr, Vet Affairs, Palo Alto, CA USA
[6] Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA 94550 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
45
引用
收藏
页数：1
相关论文
共 31 条
  • [21] New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen, N
    Yagen, B
    Bialer, M
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (02) : 203 - 211
  • [22] Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy
    Robert W. Read
    James R. Riches
    Jacqueline A. Stevens
    Sarah J. Stubbs
    Robin M. Black
    Archives of Toxicology, 2010, 84 : 25 - 36
  • [23] Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy
    Read, Robert W.
    Riches, James R.
    Stevens, Jacqueline A.
    Stubbs, Sarah J.
    Black, Robin M.
    ARCHIVES OF TOXICOLOGY, 2010, 84 (01) : 25 - 36
  • [24] Evaluation of oxime efficacy in nerve agent poisoning: Development of a kinetic-based dynamic model
    Worek, F
    Szinicz, L
    Eyer, P
    Thiermann, H
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 209 (03) : 193 - 202
  • [25] THE RELATIONSHIP BETWEEN NERVE-TERMINAL ADENOSINE TRIPHOSPHATASES AND NEUROTRANSMITTER RELEASE - AS DETERMINED BY THE USE OF ANTI-DEPRESSANT AND OTHER CNS-ACTIVE DRUGS
    GILBERT, JC
    WYLLIE, MG
    BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (02) : 215 - 225
  • [26] Beneficial Aement of A Combined Tropicamide and Various Oxime Treatments Against Miosis and Visual Dysfunction Following Ocular Exposure to the Nerve Agent Sarin
    Gore, Ariel
    Bloch-Shilderman, Eugenia
    Egoz, Inbal
    Brandeis, Rachel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [27] Beneficial assessment of a combined tropicamide and various oxime treatments against miosis and visual dysfunction following ocular exposure to the nerve agent sarin
    Gore, A.
    Bloch-Shilderman, E.
    Egoz, I
    Turetz, J.
    Brandeis, R.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 : S19 - S20
  • [28] Development of a Larval Zebrafish Model for Acute Organophosphorus Nerve Agent and Pesticide Exposure and Therapeutic Evaluation
    Koenig, Jeffrey A.
    Acon Chen, Cindy
    Shih, Tsung-Ming
    TOXICS, 2020, 8 (04) : 1 - 11
  • [29] Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure
    Tetz, Lauren M.
    Rezk, Peter E.
    Ratcliffe, Ruthie H.
    Gordon, Richard K.
    Steele, Keith E.
    Nambiar, Madhusoodana P.
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2006, 22 (06) : 255 - 266
  • [30] Electrophysiological drug-screening of bispyridinium-non-oxime-compounds on human nicotinic α7 acetylcholine receptors - an alternative approach for the treatment of nerve agent poisoning -
    Scheffel, C.
    Rappenglck, S.
    Niessen, K.
    Worek, F.
    Thiermann, H.
    Wanner, K.
    Seeger, T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S42 - S42
1234